What Is AOD-9604?
AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (HGH), specifically amino acids 176–191. It was originally developed to isolate the lipolytic (fat metabolism) properties of growth hormone without activating its growth-promoting effects.
In laboratory settings, it has been studied for its potential influence on:
• Lipolysis (fat breakdown)
• Inhibition of lipogenesis (fat formation)
• Metabolic regulation pathways
AOD-9604 is often categorized under our broader Metabolic Research category, which includes compounds studied for adipose signaling and metabolic pathway research
Importantly, this peptide is categorized as a research-use compound and is not approved for human consumption.
Mechanism of Action in Research Models
Preclinical research suggests AOD-9604 may:
1. Stimulate beta-3 adrenergic receptor pathways
2. Increase hormone-sensitive lipase activity
3. Inhibit acetyl-CoA carboxylase activity (lipogenesis pathway)
Unlike full-length growth hormone, studies indicate that the 176-191 fragment does not stimulate IGF-1 production or promote cell proliferation in the same way.
Relevant research discussions can be found in peer-reviewed literature indexed on PubMed:
• Growth hormone fragment 176-191 lipolytic activity research (view source)
• Mechanistic studies on GH fragments and adipose tissue metabolism (view source)
Why Researchers Study AOD-9604
Scientists are interested in studying this peptide because it represents a targeted metabolic pathway approach:
• Selective fat metabolism signaling
• Minimal impact on growth pathways
• Potential therapeutic modeling for metabolic disorders
This makes it a valuable compound for laboratory research into obesity models and metabolic signaling systems
Research Limitations
Human clinical data remains limited. While early phase trials have been explored in obesity research contexts, AOD-9604 remains classified for investigational use.
For broader peptide metabolism discussions, see:
• Peptides in obesity research review (view source)
Conclusion
AOD-9604 remains an intriguing compound in metabolic pathway research due to its selective lipolytic signaling properties. Continued investigation is required to further understand its molecular targets and long-term safety profile in experimental settings.
